
Hot Property: Vor Biopharma
Vor Biopharma will expand at 100 Cambridgepark Drive with the construction of an in-house clinical manufacturing facility, growing its footprint to 75,000 square feet on three floors.
Vor Biopharma will expand at 100 Cambridgepark Drive with the construction of an in-house clinical manufacturing facility, growing its footprint to 75,000 square feet on three floors.
A 143,616-square-foot Bedford lab building that includes the headquarters of Homology Medicines Inc. has been acquired by Quincy-based Jumbo Capital Management and Iron Point Partners for $72.5 million.
Harvard University has received proposals from nine teams of developers to lead the first phase of its planned 36-acre Enterprise Research Campus in Allston.
Upgrading office and industrial buildings to lab-ready space is paying off for a growing field of developers hoping to snare the next hot biotech startup transitioning from early-stage research to commercialization.
During his 22-year career, Adam Sichol has had a front-row seat on the life science industry’s expansion into Greater Boston’s most dynamic commercial real estate sector and played a hand in companies’ growth and relocations.
An office and lab building near Harvard Square has sold for $128 million, approaching the local record price-per-square-foot for life science space in Greater Boston.
Boston-based Longfellow Real Estate Partners is making a $321 million bet on the future of life science in the San Francisco area with a minority investment in a nearly 1-million-square-foot tech park.
Boston-based Longfellow Real Estate Partners has raised $500 million in a new fund that will acquire tech and life science properties across the U.S.
Three office buildings in Cambridge’s revitalized Alewife submarket have sold for a combined $370.2 million to a partnership of Longfellow Real Estate Partners and Morgan Stanley.